About this trial
This project intends to conduct a multicenter retrospective study to evaluate the satisfactory reduction of advanced ovarian cancer using PET-CT images, and explore the correlation between molecular biological characteristics and clinical characteristics of ovarian cancer through high-throughput sequencing genomics combined with radiomics.
Eligibility criteria
Qualifiers
Pathological type is epithelial ovarian cancer.
Underwent primary debulking surgery at our hospital.
Postoperative pathological staging is FIGO stage IIB or above.
Clinical, surgical, and pathological data of the patient are mostly complete.
Disqualifiers
Pathological type is non-epithelial ovarian cancer.
Underwent fertility-preserving surgery or palliative surgery.
Presence of infection during PET/CT image acquisition.
Concurrent other malignant tumors.
Trial design
Treatments tested in this trial
- Radio-score